The improved antitumor efficacy of continuous intratumoral chemotherapy with cisplatin-loaded implants for the treatment of sarcoma 180 tumor-bearing mice
Cisplatin is the most commonly used antitumor drug in the chemotherapy of a variety of malignancies. However, the severe side effects and drug resistance limit its clinical application. The aim of this study was to develop PLGA-based cisplatin-loaded implants and evaluate the antitumor efficacy of c...
Main Authors: | Li Gao, Shang Cai, Awei Cai, Yang Zhao, Tangbing Xu, Yan Ma, Yan Xu, Yuan Wang, Hao Wang, Yong Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2019.1574938 |
Similar Items
-
Assessment of the feasibility of TACE combined with intratumoral injection of cisplatin in hepatocellular carcinoma
by: Zhaomin Song, et al.
Published: (2015-01-01) -
Enhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice
by: Gao L, et al.
Published: (2017-10-01) -
Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
by: Chunsheng Wu, et al.
Published: (2020-01-01) -
Intratumoral Administration of a Novel Cytotoxic Formulation with Strong Tissue Dispersive Properties Regresses Tumor Growth and Elicits Systemic Adaptive Immunity in In Vivo Models
by: Lewis H. Bender, et al.
Published: (2020-06-01) -
Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon
by: Patrícia Alessandra Dastoli, et al.
Published: (2011-02-01)